These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 10344289)

  • 1. Glial fibrillary acidic protein and its fragments discriminate astrocytoma from oligodendroglioma.
    Luider TM; Kros JM; Sillevis Smitt PA; van den Bent MJ; Vecht CJ
    Electrophoresis; 1999; 20(4-5):1087-91. PubMed ID: 10344289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clarifying the diffuse gliomas: an update on the morphologic features and markers that discriminate oligodendroglioma from astrocytoma.
    Gupta M; Djalilvand A; Brat DJ
    Am J Clin Pathol; 2005 Nov; 124(5):755-68. PubMed ID: 16203285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of glial fibrillary acidic protein (GFAP) with grading of the neuroglial tumours.
    Reyaz N; Tayyab M; Khan SA; Siddique T
    J Coll Physicians Surg Pak; 2005 Aug; 15(8):472-5. PubMed ID: 16202357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of non-glial intermediate filament proteins in gliomas.
    Hirato J; Nakazato Y; Ogawa A
    Clin Neuropathol; 1994; 13(1):1-11. PubMed ID: 7518371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligodendrogliomas result from the expression of an activated mutant epidermal growth factor receptor in a RAS transgenic mouse astrocytoma model.
    Ding H; Shannon P; Lau N; Wu X; Roncari L; Baldwin RL; Takebayashi H; Nagy A; Gutmann DH; Guha A
    Cancer Res; 2003 Mar; 63(5):1106-13. PubMed ID: 12615729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GFAP-positive neoplastic astrocytes in spontaneous oligodendrogliomas and mixed gliomas of rats.
    Nagatani M; Yamakawa S; Saito T; Ando R; Hoshiya T; Tamura K; Uchida K
    Toxicol Pathol; 2013; 41(4):653-61. PubMed ID: 23076037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cell proliferation and glial fibrillary acidic protein in brain tumors].
    Kunz J; Gottschalk J; Jänisch W; Schulz W
    Acta Histochem; 1986; 80(1):53-61. PubMed ID: 3099535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinicopathological study of oligodendroglioma with special reference to immunohistochemical investigation].
    Kubo O; Tajika Y; Toyama T; Tajika T; Sakairi M; Katahira M; Kitamura K
    No Shinkei Geka; 1988 Aug; 16(9):1029-35. PubMed ID: 2462693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of glial fibrillary acidic protein and protein S-100 in cerebral astrocytic gliomas of varying degrees of malignancy (immunohistochemical study)].
    Korshunov AG; Sycheva RV
    Arkh Patol; 1995; 57(4):30-8. PubMed ID: 8526753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uniform lineage of oligodendrogliomas.
    de la Monte SM
    Am J Pathol; 1989 Sep; 135(3):529-40. PubMed ID: 2675625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligodendrogliomas in relation to astrocytes differentiation. Clinicopathologic and immunohistochemical study.
    Tena-Suck ML; Moreno-Jiménez S; Alonso M; Aguirre-Crux L; Sánchez A
    Ann Diagn Pathol; 2008 Oct; 12(5):313-21. PubMed ID: 18774492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of monoclonal antibodies to glial fibrillary acidic protein in the cytologic diagnosis of brain tumors.
    Chen Y; Zhang YX
    Acta Cytol; 1989; 33(6):922-8. PubMed ID: 2588925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GFAP in brain tumor diagnosis: possibilities and limitations.
    Gullotta F; Schindler F; Schmutzler R; Weeks-Seifert A
    Pathol Res Pract; 1985 Jul; 180(1):54-60. PubMed ID: 4034433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [MBP and GFAP immunohistochemistry of oligodendrogliomas with relationship to myelin-forming glia in cell differentiation].
    Hokama Y; Tanaka J; Nakamura H; Hori T
    No To Shinkei; 1986 Apr; 38(4):379-86. PubMed ID: 2424482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Significance of immunohistochemistry for neuro-oncology. VI. Occurrence, localization and distribution of glial fibrillary acid protein (GFAP) in 820 tumors].
    Gottschalk J; Szymaś J
    Zentralbl Allg Pathol; 1987; 133(4):319-30. PubMed ID: 3425011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An immunocytochemical comparison of glial fibrillary acidic protein, S-100p and vimentin in human glial tumors.
    Nakopoulou L; Kerezoudi E; Thomaides T; Litsios B
    J Neurooncol; 1990 Feb; 8(1):33-40. PubMed ID: 2319288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astrocytes give rise to oligodendrogliomas and astrocytomas after gene transfer of polyoma virus middle T antigen in vivo.
    Holland EC; Li Y; Celestino J; Dai C; Schaefer L; Sawaya RA; Fuller GN
    Am J Pathol; 2000 Sep; 157(3):1031-7. PubMed ID: 10980141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunohistochemical study on Rosenthal fibers in gliomas using anti-GFAP and anti-ubiquitin antibodies].
    Kobayashi S; Mori H; Ikeuchi S; Takakura K
    No To Shinkei; 1990 Jan; 42(1):59-64. PubMed ID: 1692468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of cell surface antigens and glial fibrillary acidic protein in human astrocytoma subsets.
    Rettig WJ; Chesa PG; Beresford HR; Feickert HJ; Jennings MT; Cohen J; Oettgen HF; Old LJ
    Cancer Res; 1986 Dec; 46(12 Pt 1):6406-12. PubMed ID: 2877731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of gliomas by morphological and immunocytochemical analysis in cell cultures.
    Fazekas I; Kerekes E; Hegedús B; Nyáry I
    Ideggyogy Sz; 2002 May; 55(5-6):173-9. PubMed ID: 12122877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.